Red-hot chipmaker AMD pops on surprise Q2 profit >>> READ MORE

5 Health Care Penny Stocks to Buy

Health care sector is free to roam, and so are these stocks

      View All  


Theragenics (TGX) logoIf the name Theragenics (NYSE:TGX) sounds familiar, you  likely heard of this stock via its heavily advertised prostate cancer treatment program. TheraSeed is an FDA-approved medical device helping to diversify this 30-year-old medical device company. Earlier this year, the $58 million market cap company received a takeover bid that would have valued Theragenics at $74 million.

Shares soared on the news of the bid to more than $2 per share, but the eventual rejection of the offer has resulted in shares drifting lower. You can buy the stock today for $1.70 per share. As acceptance of its prostate treatment gains momentum, look for TGX to soar higher.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC